Non-Surgical Kidney Cancer Treatment Helps Patient

Joseph Polaniecki has been through a lot in his 87 years.

A Holocaust survivor, he immigrated to the United States in 1951 with his 9-months pregnant wife, Doris, a few possessions and no grasp of the English language. They welcomed their first child—a son—just nine days after arriving in Cincinnati and starting a new life in America. It took him five months to find work—and he landed that first job through sheer determination and perseverance.

Those traits also served him well later in life in another journey: Polaniecki is also a two-time kidney cancer survivor.

He was first diagnosed with the disease in 2005, undergoing a successful radiofrequency ablation of a small tumor in his left kidney. In 2011, a similar tumor in the backside of his right kidney was detected and needed medical intervention.

James Donovan, MD, chief of urology at the University of Cincinnati College of Medicine and urologist with UC Health, suggested an innovative technique known as computed tomography (CT)-guided percutaneous cryoablation. The procedure uses 3-D imaging technology to direct a small probe through the skin and into the kidney to freeze cancerous tissue, sparing the patient from major open surgery.

 

"Patients with posterior tumors—embedded deep in the backside of the kidney—typically don’t qualify for minimally invasive surgery because the tumors are hard to access,” says Donovan. "Cryoablation spares patients like Mr. Polaniecki of drastic open surgery and still provides good cancer control. The CT-guidance improves the effectiveness of the treatment.”

 

Clinical data has shown that removing only the tumor and sparing the rest of the kidney is as effective in curing cancer as removing the entire organ in certain patients.

 

"I had no pain whatsoever from the cryoablation and so far I’m doing great,” says Polaniecki. "I was about to get on a plane to go to California to be treated by the person who was doing the most kidney cryoablation cases nationwide, but Dr. Donovan made that care available right here in Cincinnati. I’m thankful I didn’t have to travel beyond my hometown to get great care.”

 

Polaniecki ’s follow-up CAT scan showed he was cancer free. Now he’s back to regular chess matches, violin practice and exercise at the Jewish Community Center. He also enjoys spending time with his two children, Elliott and Judy; four grandchildren; and one great-grandchild.

 

Urologists with UC Health perform CT-guided cryoablation procedures of the kidney at West Chester Hospital. For more information on UC Health urology services, visit ucphysicians.com or call (513) 475-8787.

UC Health urologists were among the first in Greater Cincinnati to offer and have significant experience performing minimally invasive partial nephrectomy—what is known as "kidney-sparing surgery”—to remove small cancerous tumors without sacrificing the entire organ, using minimally invasive techniques. The team also offers cryoablation to treat certain localized prostate cancers.

CT scan of a small renal tumor, prior to cryoablation

CT scan of a small renal tumor, prior to cryoablation

A small renal tumor three months after cryoablation

A small renal tumor three months after cryoablation

James Donovan, MD, is chief of the division of urology at UC.

James Donovan, MD, is chief of the division of urology at UC.

Related Stories

1

$15 million bequest supports endowed chair at UC College of Medicine

May 19, 2026

As a student and resident at the University of Cincinnati College of Medicine, George G. Bemis, Jr., MD, Med ’64, saw firsthand that medicine was more than a profession for those teaching and leading him. Inspired by their sense of calling, he knew he wanted to pursue the same path.

3

Driven by curiosity, guided by care

May 14, 2026

Max Wilson, a University of Cincinnati College of Allied Health Sciences health sciences major on the pre-physician assistant track, found his path expanding beyond the classroom and into hands-on research focused on human performance and patient care.